NEW YORK NY--(Marketwire - April 14, 2010) - Corporate Profile's newest financial website, www.CPreports.com announces an Update. Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, has issued a research update on Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best-in-class oncology and CNS therapeutics. See update at www.cpreports.com or http://www.cpreports.com/?p=141